Therapeutic options in male genital tract inflammation.


Journal

Andrologia
ISSN: 1439-0272
Titre abrégé: Andrologia
Pays: Germany
ID NLM: 0423506

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 23 07 2018
revised: 25 09 2018
accepted: 15 10 2018
pubmed: 27 11 2018
medline: 15 6 2019
entrez: 27 11 2018
Statut: ppublish

Résumé

Chronic inflammatory conditions of the genital tract are still unsatisfactorily recognised in the workup of male infertility due to inappropriate definitions and inconsistent diagnostic criteria. The most popular term used for description of both, infections and inflammation in the genital tract is MAGI (male accessory gland infection). In asymptomatic patients, the diagnosis is primarily based on leucocytospermia (i.e., more than 1 million peroxidase-positive leucocytes per ml ejaculate), although ongoing infections should be identified and distinguished from post-infectious or non-infectious inflammatory disease. In addition to alterations of the basic semen parameters, sperm functions -and DNA integrity may be affected by chronic inflammation of the male genital tract. Despite considerable diagnostic drawbacks and a rather limited database concerning evidence-based therapy, adequate management of affected patients appears mandatory. Antibiotic treatment aims at the eradication or reduction of pathogenic bacteria in the ejaculate. Available studies suggest, that NSAID are effective in chronic inflammatory conditions. Moreover, low-dose corticosteroids, mast cell blockers, and other immune-modulatory compounds as well as a sequential adjuvant treatment with antioxidants can be considered as therapeutic options.

Identifiants

pubmed: 30474250
doi: 10.1111/and.13207
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13207

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 Blackwell Verlag GmbH.

Auteurs

Gerhard Haidl (G)

Andrology Unit, Department of Dermatology and Allergy, University Hospital Bonn, Bonn, Germany.

Friederike Haidl (F)

Department of Urology, University Hospital Cologne, Cologne, Germany.

Jean-Pierre Allam (JP)

Andrology Unit, Department of Dermatology and Allergy, University Hospital Bonn, Bonn, Germany.

Hans-Christian Schuppe (HC)

Department of Urology, Pediatric Urology and Andrology, Justus Liebig University, Giessen, Germany.
Hessian Centre of Reproductive Medicine, Justus Liebig University, Giessen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH